Glucocorticoids suppress inflammation via the upregulation of negative regulator IRAK-M

Nature Communications

Volumn 6, Issue , 2015, Pages

  Miyata, Masanori ^a   Lee, Ji Yun ^a   Susuki Miyata, Seiko ^a   Wang, Wenzhuo Y ^a,b   Xu, Haidong ^a   Kai, Hirofumi ^c   Kobayashi, Koichi S ^d   Flavell, Richard A ^e   Li, Jian Dong ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c KUMAMOTO UNIVERSITY   (Japan)

^d TEXAS A M COLLEGE OF MEDICINE   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 3; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; RANTES; SMALL INTERFERING RNA; SYNAPTOTAGMIN I; TOLL LIKE RECEPTOR 2; GLUCOCORTICOID; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; IRAK3 PROTEIN, HUMAN; IRAK3 PROTEIN, MOUSE;

BACTERIUM; CYTOLOGY; ENZYME ACTIVITY; RODENT; SIGNALING; STEROID; SURVIVAL; WILD POPULATION;

A549 CELL LINE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CLEARANCE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DELETION MUTANT; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INFLAMMATION; INNATE IMMUNITY; LUNG ALVEOLUS MACROPHAGE; LUNG ALVEOLUS WALL; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; NONTYPEABLE HAEMOPHILUS INFLUENZAE; PNEUMONIA; PROMOTER REGION; PROTEIN EXPRESSION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SURVIVAL RATE; UPREGULATION; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CELL LINE; GENETICS; HAEMOPHILUS INFLUENZAE; IMMUNOLOGY; METABOLISM; PATHOGENICITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

HAEMOPHILUS INFLUENZAE; MUS;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; GLUCOCORTICOIDS; HAEMOPHILUS INFLUENZAE; HUMANS; INFLAMMATION; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; MALE; MICE; MICE, INBRED C57BL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 84923104586     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms7062     Document Type: Article

References (64)

1. Quax, R. A. et al. Glucocorticoid sensitivity in health and disease. Nat. Rev. Endocrinol. 9, 670-686 (2013).
2. Clark, A. R.&Belvisi, M. G. Maps and legends: the quest for dissociated ligands of the glucocorticoid receptor. Pharmacol. Ther. 134, 54-67 (2012).
3. Beck, I. M. et al. Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases. Endocr. Rev. 30, 830-882 (2009).
4. Luecke, H. F.&Yamamoto, K. R. The glucocorticoid receptor blocks P-TEFb recruitment by NFkappaB to effect promoter-specific transcriptional repression. Genes Dev. 19, 1116-1127 (2005).
5. Busillo, J. M.&Cidlowski, J. A. The five Rs of glucocorticoid action during inflammation: ready, reinforce, repress, resolve, and restore. Trends Endocrinol. Metab. 24, 109-119 (2013).
6. Kadmiel, M.&Cidlowski, J. A. Glucocorticoid receptor signaling in health and disease. Trends Pharmacol. Sci. 34, 518-530 (2013).
7. Surjit, M. et al. Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor. Cell 145, 224-241 (2011).
8. Uhlenhaut, N. H. et al. Insights into negative regulation by the glucocorticoid receptor from genome-wide profiling of inflammatory cistromes. Mol. Cell 49, 158-171 (2013).
9. Kawai, T.&Akira, S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11, 373-384 (2010).
10. Kondo, T., Kawai, T.&Akira, S. Dissecting negative regulation of Toll-like receptor signaling. Trends Immunol. 33, 449-458 (2012).
11. von Bernuth, H. et al. Pyogenic bacterial infections in humans with MyD88 deficiency. Science 321, 691-696 (2008).
12. Adachi, O. et al. Targeted disruption of the MyD88 gene results in loss of IL-1-and IL-18-mediated function. Immunity 9, 143-150 (1998).
13. Janssens, S.&Beyaert, R. Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Mol. Cell 11, 293-302 (2003).
14. Hassan, F. et al. Involvement of interleukin-1 receptor-associated kinase (IRAK)-M in toll-like receptor (TLR) 7-mediated tolerance in RAW 264.7 macrophage-like cells. Cell. Immunol. 256, 99-103 (2009).
15. Deng, J. C. et al. Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M. J. Clin. Invest. 116, 2532-2542 (2006).
16. Kobayashi, K. et al. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110, 191-202 (2002).
17. Berglund, M. et al. IL-1 receptor-associated kinase M downregulates DSS-induced colitis. Inflamm. Bowel Dis. 16, 1778-1786 (2010).
18. Standiford, T. J. et al. TGF-beta-induced IRAK-M expression in tumorassociated macrophages regulates lung tumor growth. Oncogene 30, 2475-2484 (2011).
19. Sumpter, T. L. et al. DAP12 promotes IRAK-M expression and IL-10 production by liver myeloid dendritic cells and restrains their T cell allostimulatory ability. J. Immunol. 186, 1970-1980 (2011).
20. van der Windt, G. J. et al. Interleukin 1 receptor-associated kinase m impairs host defense during pneumococcal pneumonia. J. Infect. Dis. 205, 1849-1857 (2012).
21. Wesche, H. et al. IRAK-M is a novel member of the Pelle/interleukin-1 receptor-associated kinase (IRAK) family. J. Biol. Chem. 274, 19403-19410 (1999).
22. Lagler, H. et al. TREM-1 activation alters the dynamics of pulmonary IRAK-M expression in vivo and improves host defense during pneumococcal pneumonia. J. Immunol. 183, 2027-2036 (2009).
23. Punturieri, A., Copper, P., Polak, T., Christensen, P. J.&Curtis, J. L. Conserved nontypeable Haemophilus influenzae-derived TLR2-binding lipopeptides synergize with IFN-beta to increase cytokine production by resident murine and human alveolar macrophages. J. Immunol. 177, 673-680 (2006).
24. Wieland, C. W. et al. The MyD88-dependent, but not the MyD88-independent, pathway of TLR4 signaling is important in clearing nontypeable haemophilus influenzae from the mouse lung. J. Immunol. 175, 6042-6049 (2005).
25. Decramer, M., Janssens, W.&Miravitlles, M. Chronic obstructive pulmonary disease. Lancet 379, 1341-1351 (2012).
26. Sethi, S.&Murphy, T. F. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N. Engl. J. Med. 359, 2355-2365 (2008).
27. Shuto, T. et al. Activation of NF-kappa B by nontypeable Hemophilus influenzae is mediated by toll-like receptor 2-TAK1-dependent NIK-IKK alpha /beta-I kappa B alpha and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells. Proc. Natl Acad. Sci. USA 98, 8774-8779 (2001).
28. Watanabe, T., Jono, H., Han, J., Lim, D. J.&Li, J. D. Synergistic activation of NF-kappaB by nontypeable Haemophilus influenzae and tumor necrosis factor alpha. Proc. Natl Acad. Sci. USA 101, 3563-3568 (2004).
29. Jono, H. et al. NF-kappaB is essential for induction of CYLD, the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway. J. Biol. Chem. 279, 36171-36174 (2004).
30. Dhawan, L., Liu, B., Blaxall, B. C.&Taubman, M. B. A novel role for the glucocorticoid receptor in the regulation of monocyte chemoattractant protein-1 mRNA stability. J. Biol. Chem. 282, 10146-10152 (2007).
31. Gille, J., Reisinger, K., Westphal-Varghese, B.&Kaufmann, R. Decreased mRNA stability as a mechanism of glucocorticoid-mediated inhibition of vascular endothelial growth factor gene expression by cultured keratinocytes. J. Invest. Dermatol. 117, 1581-1587 (2001).
32. Robertson, S. et al. Abrogation of glucocorticoid receptor dimerization correlates with dissociated glucocorticoid behavior of compound a. J. Biol. Chem. 285, 8061-8075 (2010).
33. Baldwin, Jr. A. S. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649-683 (1996).
34. Truax, A. D.&Greer, S. F. ChIP and Re-ChIP assays: investigating interactions between regulatory proteins, histone modifications, and the DNA sequences to which they bind. Methods Mol. Biol. 809, 175-188 (2012).
35. Suzuki, N. et al. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 416, 750-756 (2002).
36. Picard, C. et al. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 299, 2076-2079 (2003).
37. Scheinman, R. I., Gualberto, A., Jewell, C. M., Cidlowski, J. A.&Baldwin, Jr. A. S. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Mol. Cell. Biol. 15, 943-953 (1995).
38. Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A.&Karin, M. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270, 286-290 (1995).
39. Kassel, O. et al. Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J. 20, 7108-7116 (2001).
40. Oda, K.&Kitano, H. A comprehensive map of the toll-like receptor signaling network. Mol. Syst. Biol. 2, 0015 (2006).
41. Li, F., Thiele, I., Jamshidi, N.&Palsson, B. O. Identification of potential pathway mediation targets in Toll-like receptor signaling. PLoS Comput. Biol. 5, e1000292 (2009).
42. Nissen, R. M.&Yamamoto, K. R. The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev. 14, 2314-2329 (2000).
43. Rao, N. A. et al. Coactivation of GR and NFKB alters the repertoire of their binding sites and target genes. Genome Res. 21, 1404-1416 (2011).
44. Su, J., Xie, Q., Wilson, I.&Li, L. Differential regulation and role of interleukin-1 receptor associated kinase-M in innate immunity signaling. Cell. Signal. 19, 1596-1601 (2007).
45. Cabanski, M. et al. Genome-wide transcriptional profiling of mononuclear phagocytes recruited to mouse lungs in response to alveolar challenge with the TLR2 agonist Pam3CSK4. Am. J. Physiol. Lung Cell. Mol. Physiol. 297, L608-L618 (2009).
46. Nakayama, K. et al. Involvement of IRAK-M in peptidoglycan-induced tolerance in macrophages. J. Biol. Chem. 279, 6629-6634 (2004).
47. Zacharioudaki, V. et al. Adiponectin promotes endotoxin tolerance in macrophages by inducing IRAK-M expression. J. Immunol. 182, 6444-6451 (2009).
48. Li, H. et al. IL-1 receptor-associated kinase M is a central regulator of osteoclast differentiation and activation. J. Exp. Med. 201, 1169-1177 (2005).
49. Balaci, L. et al. IRAK-M is involved in the pathogenesis of early-onset persistent asthma. Am. J. Hum. Genet. 80, 1103-1114 (2007).
50. Seki, M. et al. Critical role of IL-1 receptor-associated kinase-M in regulating chemokine-dependent deleterious inflammation in murine influenza pneumonia. J. Immunol. 184, 1410-1418 (2010).
51. van 't Veer, C. et al. Induction of IRAK-M is associated with lipopolysaccharide tolerance in a human endotoxemia model. J. Immunol. 179, 7110-7120 (2007).
52. Medzhitov, R., Schneider, D. S.&Soares, M. P. Disease tolerance as a defense strategy. Science 335, 936-941 (2012).
53. Tournoy, K. G., Kips, J. C., Schou, C.&Pauwels, R. A. Airway eosinophilia is not a requirement for allergen-induced airway hyperresponsiveness. Clin. Exp. Allergy 30, 79-85 (2000).
54. Kwak, Y. G. et al. Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma. J. Clin. Invest. 111, 1083-1092 (2003).
55. Matute-Bello, G. et al. An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am. J. Respir. Cell Mol. Biol. 44, 725-738 (2011).
56. Hu, H. L., Zhang, Q., Kong, B.&Shi, X. Expression of pancreatic regenerating gene in lung and intestinal tissue correlates with the severity of disease in rats with acute necrotizing pancreatitis. Mol. Med. Rep. 7, 503-508 (2013).
57. Erwin, A. L.&Smith, A. L. Nontypeable Haemophilus influenzae: understanding virulence and commensal behavior. Trends Microbiol. 15, 355-362 (2007).
58. Yoshida, H., Jono, H., Kai, H.&Li, J. D. The tumor suppressor cylindromatosis (CYLD) acts as a negative regulator for toll-like receptor 2 signaling via negative cross-talk with TRAF6 AND TRAF7. J. Biol. Chem. 280, 41111-41121 (2005).
59. Lim, J. H. et al. CYLD negatively regulates transforming growth factor-betasignalling via deubiquitinating Akt. Nat. Commun. 3, 771 (2012).
60. Komatsu, K. et al. Inhibition of PDE4B suppresses inflammation by increasing expression of the deubiquitinase CYLD. Nat. Commun. 4, 1684 (2013).
61. Mercurio, F. et al. IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 278, 860-866 (1997).
62. Ishinaga, H. et al. TGF-beta induces p65 acetylation to enhance bacteriainduced NF-kappaB activation. EMBO J. 26, 1150-1162 (2007).
63. Johannessen, C. M. et al. COT drives resistance to RAF inhibition through MAP kinase pathway reactivation. Nature 468, 968-972 (2010).
64. Wang, J. C. et al. Chromatin immunoprecipitation (ChIP) scanning identifies primary glucocorticoid receptor target genes. Proc. Natl Acad. Sci. USA 101, 15603-15608 (2004).